Table 3: Updated Base-Case Analysis Resultsa.
| Treatment | Costs | LYs | QALYs | ΔCost/Δ LY | ΔCost/Δ QALY |
|---|---|---|---|---|---|
| Inoperable | |||||
| TAVI | $73,196 | 4.037 | 2.702 | — | — |
| ST | $57,963 | 3.186 | 2.074 | — | — |
| Incremental (TAVI versus ST) | $15,233 | 0.851 | 0.628 | $17,898 | $24,257 |
| Operable | |||||
| TAVI | $69,960 | 4.091 | 2.945 | — | — |
| sAVR | $74,602 | 4.079 | 3.014 | — | — |
| Incremental (TAVI versus sAVR) | −$4,642 | 0.012 | −0.069 | Dominates | $66,985 |
Abbreviations: LY, life-year; QALY, quality-adjusted life-year; sAVR, surgical aortic valve replacement; ST, standard treatment; TAVI, transcatheter aortic valve implantation.
a
All amounts are in Canadian dollars. Calculations may be inexact due to rounding.